Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Beers

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2023
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and ChallengesSean H Lim, Stephen A Beers, Aymen Al-Shamkhani, et al.
International Journal of Molecular Sciences|February 25, 2023
Tri-Lineage Differentiation Potential of Osteosarcoma Cell Lines and Human Bone Marrow Stromal Cells from Different Anatomical LocationsHannah L Smith, Juliet C Gray, Stephen A Beers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 26, 2024
Developing a 3D bone model of osteosarcoma to investigate cancer mechanisms and evaluate treatmentsHannah L Smith, Stephen A Beers, Janos M Kanczler, et al.
Biochimica Et Biophysica Acta. General Subjects|August 31, 2023
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activationHannah Bauer-Smith, Abigail S L Sudol, Stephen A Beers, et al.
International Journal of Molecular Sciences|August 6, 2020
The Role of Pre-Clinical 3-Dimensional Models of OsteosarcomaHannah L Smith, Stephen A Beers, Juliet C Gray, et al.
Antibodies (Basel, Switzerland)|November 20, 2020
Fc-Engineering for Modulated Effector Functions-Improving Antibodies for Cancer TreatmentRena Liu, Robert J Oldham, Emma Teal, et al.
Biochemistry|June 18, 2003
Effect of tryptophan insertions on the properties of the human group IIA phospholipase A2: mutagenesis produces an enzyme with characteristics similar to those of the human group V phospholipase A2Stephen A Beers, Andrew G Buckland, Niroshini Giles, et al.
Cancers|May 13, 2023
Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic StrategiesConstantinos Savva, Ellen Copson, Peter W M Johnson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Therapeutic (high) doses of rituximab activate calcium mobilization and inhibit B-cell growth via an unusual mechanism triggered independently of both CD20 and Fcgamma receptorsTammy L Unruh, Jonathan Zuccolo, Stephen A Beers, et al.
Cancer Research|June 7, 2017
TLR-3/9 Agonists Synergize with Anti-ErbB2 mAb-LetterAnna H Turaj, Lekh N Dahal, Stephen A Beers, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2023
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and ChallengesSean H Lim, Stephen A Beers, Aymen Al-Shamkhani, et al.
International Journal of Molecular Sciences|February 25, 2023
Tri-Lineage Differentiation Potential of Osteosarcoma Cell Lines and Human Bone Marrow Stromal Cells from Different Anatomical LocationsHannah L Smith, Juliet C Gray, Stephen A Beers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 26, 2024
Developing a 3D bone model of osteosarcoma to investigate cancer mechanisms and evaluate treatmentsHannah L Smith, Stephen A Beers, Janos M Kanczler, et al.
Biochimica Et Biophysica Acta. General Subjects|August 31, 2023
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activationHannah Bauer-Smith, Abigail S L Sudol, Stephen A Beers, et al.
International Journal of Molecular Sciences|August 6, 2020
The Role of Pre-Clinical 3-Dimensional Models of OsteosarcomaHannah L Smith, Stephen A Beers, Juliet C Gray, et al.
Antibodies (Basel, Switzerland)|November 20, 2020
Fc-Engineering for Modulated Effector Functions-Improving Antibodies for Cancer TreatmentRena Liu, Robert J Oldham, Emma Teal, et al.
Biochemistry|June 18, 2003
Effect of tryptophan insertions on the properties of the human group IIA phospholipase A2: mutagenesis produces an enzyme with characteristics similar to those of the human group V phospholipase A2Stephen A Beers, Andrew G Buckland, Niroshini Giles, et al.
Cancers|May 13, 2023
Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic StrategiesConstantinos Savva, Ellen Copson, Peter W M Johnson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Therapeutic (high) doses of rituximab activate calcium mobilization and inhibit B-cell growth via an unusual mechanism triggered independently of both CD20 and Fcgamma receptorsTammy L Unruh, Jonathan Zuccolo, Stephen A Beers, et al.
Cancer Research|June 7, 2017
TLR-3/9 Agonists Synergize with Anti-ErbB2 mAb-LetterAnna H Turaj, Lekh N Dahal, Stephen A Beers, et al.
Pageof 8